Loading…
Loading…
MGHL does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for MGHL and 80,000+ other tickers.
See exactly how MGHL's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for MGHL and 80,000+ other tickers.
Operating through its subsidiary G.research, LLC, Morgan Group Holding Co. extends institutional research and securities brokerage services throughout the United States. A core aspect of its operations involves producing research reports for approximately 100 companies, with a particular focus on small and mid-capitalization investments. The firm also offers syndicated underwriting services. Its extensive client base encompasses institutional investors, mutual funds, asset management firms, private wealth managers, and individual retail customers. Morgan Group Holding Co. was founded in 2001 and maintains its principal place of business in Rye, New York.
Morgan Stanley analyst Adam Jonas is telling investors they still aren't grasping the full scale of SpaceX's ambitions, even after the company unveiled a $100 billion spaceport plan in Louisiana.
Kinder Morgan delivered record Q2 net income and adjusted EBITDA and raised 2026 guidance, yet shares remain 11% below their 52-week high. KMI benefits from surging U.S. natural gas demand, with a $9.6B backlog, 40% market share in gas transport, and robust contracted cash flows. The 3.8% dividend yield is covered over 2x by distributable cash flow, with leverage at 3.6x and self-funded growth supporting further dividend increases.
SAN DIEGO--(BUSINESS WIRE)--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated small molecule therapies for inflammatory and fibrotic diseases with significant unmet need, today announced that management is scheduled to present at the 2026 Morgan Stanley Global Healthcare Conference on Tuesday, September 15th at 5:35 p.m. ET. An audio webcast of the fireside chat can be accessed on the Investors section of.
OMAHA, Neb.--(BUSINESS WIRE)--Werner Enterprises, Inc. (Nasdaq: WERN), a premier transportation and logistics provider, announced participation in the following investment conference. Morgan Stanley's 14th Annual Laguna Conference: Tuesday, September 15th, 2026, in Laguna Beach, California, including investor meetings. Members of Werner's management team will participate in a fireside chat presentation from 12:20 p.m. to 12:55 p.m. PT. A live webcast for the conference may be available on the c.
MS outpaces peers with a 45.1% share price gain, but trading cyclicality, rising expenses and a premium valuation could limit further upside.